May 17 (Reuters) – Artificial heart manufacturer Carmat was down sharply on the Paris Stock Exchange on Friday after announcing a fundraising of 16 million euros, its second capital increase this year.
Carmat shares fell 25.16% to 2.99 euros at 09:11 GMT.
The group announced on Friday that it had raised a total gross amount of 16 million euros, including 14.2 million euros subscribed by specialized investors and 1.8 million by individual investors.
This new financing is essential for the group, in particular to meet the growing demand for its Aeson artificial heart, said Stéphane Piat, general director of the group, in a press release.
However, at a price of 3 euros per new share issued, the discount is 24.8% compared to the closing price of the stock on Thursday, which was 3.99 euros.
With this second increase this year, Carmat has financial visibility until August, writes Mohamed Kaabouni, analyst at Portzamparc, in a note to clients.
The group will need an additional 30 million euros to have a 12-month cash horizon, he added.
(Writing by Diana Mandiá, with Dagmarah Mackos; editing by Kate Entringer)
©2024 Thomson Reuters, all rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. “Reuters” and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.